The pharmaceutical industry is a key player in a new partnership that aims to bring the public and private sectors together to address future complex health threats.
A “roadmap” that will set out suggestions for tackling global pandemics, including plans to develop and deploy new vaccines and treatments in just 100 days, is to be presented at a gathering of leaders of the G7 group of countries in the UK on 11 June.
The announcement was made during the 3-4 June meeting of G7 health ministers in Oxford at which the emerging recommendations...
<p>Executive Summary</p> <p>A list of EU biosimilar filings, CHMP opinions and EU marketing authorizations, including details of the biosimilar company, the brand name/INN, indication(s), the reference product/company, and the date and type of event.</p>
As the reform of the EU pharmaceutical legislation progresses through the legislative process, the Pinks Sheet offers an infographic highlighting some of the key changes being proposed that will reshape the way drug companies run their business.
<p>Executive Summary<p> <p>The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add six new products, incl/ding Ixchiq, Valneva's chikungunya virus vaccine</p>
A new research ethics review system for multi-site clinical trials in Canada is expected to help improve study start-up times, avoid unnecessary duplication and boost the country’s competitiveness on a global stage.
With the deadline for comments on the US FDA’s draft guidance less than a month away, the Pink Sheet offers an infographic outlining what the agency is expecting in diversity action plans and when that might be implemented.
